Market Cap 27.14M
Revenue (ttm) 19.89M
Net Income (ttm) -131.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -661.99%
Debt to Equity Ratio 0.00
Volume 732,200
Avg Vol 453,776
Day's Range N/A - N/A
Shares Out 67.01M
Stochastic %K 7%
Beta 2.73
Analysts Sell
Price Target $6.75

Latest News on GBIO

Generation Bio Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 4:15 PM EDT - 1 year ago

Generation Bio Reports Second Quarter 2023 Financial Results


Generation Bio, Moderna announce collaboration

Mar 23, 2023, 7:44 AM EDT - 2 years ago

Generation Bio, Moderna announce collaboration

MRNA